 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/656029
The North America Biotechnology Sectors : A Company and Industry Analysis (February 2006)
|
Description: |
This report looks at the biotechnology industry in the United States and Canada
Current Environment - Key Points
- Large-cap biotechs in the US made big gains in 2005 as reflected by the 27% increase of the AMEX Biotech Index
The NASDAQ Biotech Index, which represents smaller biotechs, mirrored the broader market with its 3% gain in the year
- The second half of 2005 saw leading biotechs in North America turn in an excellent performance demonstrated by rising revenues, stable cash position, active research and development (R&D) activities and strong growth prospects
- The news about a potential outbreak of the avian flu has shaken the long dormant vaccine business
It has driven a consolidation of the vaccine business in North America while spurring efforts in biotech companies to find new ways to develop and manufacture vaccines much more efficiently
- In the second half of 2005, there were eight biotech IPOs completed in the US and two in Canada
Industry Profile - Key Points
- There are currently about 1,473 biotech companies in the US
The US biotech industry has been growing at double digit rates annually according to Biotechnology Industry Organization (BIO)
In 2004, the industry generated sales of $46 billion, up from $8 billion in 1992
- Canada has about 450 biotech companies
It is ranked third behind the US and UK in terms of revenues, but is ranked first in the world in terms of R&D expenditure per employee according to BIOTECanada
- In the US, total financing increased consistently during each successive quarter up until the third quarter in 2005
Total investment in venture capital (VC) in the third quarter was up 7% from the corresponding quarter in 2004, according to Burril & Co, a San Francisco-based global life sciences merchant bank
- In Canada, VC investment in life sciences tracked by Canadian VC expert, Macdonald & Associates, fell 32% in the third quarter of 2005 from the corresponding quarter in 2004, as investors withdrew from all sectors following a very active second quarter
Market Trends and Outlook - Key Points
- Industrial and environmental biotech is causing other industrial sectors such as chemicals and paper, to adopt efficient and environmental friendly biotech applications to replace conventional methods in their operations
- More states in the US are developing strong local ethanol industries to make themselves less dependent upon outside sources of energy
There are currently 93 ethanol plants with at least ten undergoing expansion and 31 additional plants under construction, according to the American Coalition for Ethanol (ACE) - The revolution of personalized medicine is attracting investors as it swiftly makes its way into the clinic driven by advances in biotech and computer software
- Canadian biotechs may face greater pricing pressures due to escalating healthcare spending in the country
Estimates by The Canadian Institute for Health Information (CIHI) showed that spending on healthcare will amount to C$142 billion (US$121.5 billion) in 2005, an increase of 7.7% over 2004
- Despite being pushed for modification, the Canadian regulatory approval for biotech products remains science-based, which means that the regulatory process involved is based upon the plants- traits rather than the method used to introduce the traits
|
|
Contents: |
Current Environment - US
- Sector Overview
- Sector Performance
- Leading Companies
- Mergers & Acquisitions and
Alliances
- Initial Public Offerings
Current Environment - Canada
- Sector Overview
- Sector Performance
- Leading Companies
- Mergers & Acquisitions and
Alliances
- Initial Public Offerings
Industry Profile - US
- Industry Size and Value
- Industry Focus
- Sector Investment
- Government Investment
- Policy and Regulatory Environment
Industry Profile - Canada
- Industry Size and Value
- Industry Focus
- Sector Investment
- Policy and Regulatory Environment
Market Trends and Outlook - US
- Industrial and Environmental
Biotech Converge
- Ethanol Production Revving Up in
the US
- Growing Interest in Personalized
Drugs
- Market Outlook
Market Trends and Outlook -
Canada
- Rising Healthcare Spending in
Canada
- Strong Acceptance of Biotech
Crops in Canada
- Canadian Regulatory Approval
Remains Science-based
- Market Outlook
Currency Conversion Table
The Scope of This Report
Key References
Comparative Data
Regional Reports Coverage
|
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/656029
Order by Fax - using the order form below
Order By Post - print the order form below and send to
 |
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2 Printed 26/11/2009 21:45:54 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
Product Name: |
The North America Biotechnology Sectors : A Company and Industry Analysis (February 2006)
|
|
Web Address: |
http://www.researchandmarkets.com/reports/656029
|
|
Office Code: |
|
OC8HJNPOUMUXU
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Electronic (PDF)
- Single User
|
|
€100.00
|
Contact information
Please enter all the information below in BLOCK CAPITALS.
 |
|
First Name: |
Last Name: |
|
Email Address: |
 |
|
Job Title: |
 |
|
Organisation: |
 |
|
Address: |
 |
|
City: |
 |
|
Postal/Zip Code: |
 |
|
Country: |
 |
|
Phone Number: |
 |
|
Fax Number: |
 |
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
 |
Page 2 of 2 Printed 26/11/2009 21:45:54
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
American Express
|
|
Diners Club
|
|
Master Card
|
|
Visa
|
|
|
|
 |
|
Cardholder's Name: |
 |
|
|
|
Cardholder's Signature: |
 |
|
|
|
Expiry Date: |
/  |
|
|
|
Card Number: |
 |
|
|
|
CVV Security Code: |
 |
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
 |
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
 |
|
 |
Please transfer funds to:
 |
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
 |
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
 |
 |
|
|